Trimethoprim-sulfamethoxazole compared with ampicillin in acute infectious exacerbations of chronic bronchitis: a double-blind, crossover study.
D000208:Acute Disease; D000328:Adult; D000368:Aged; D000667:Ampicillin / Q000008:administration & dosage* / Q000627:therapeutic use; D001424:Bacterial Infections / Q000188:drug therapy*; D001991:Bronchitis / Q000188:drug therapy* / Q000473:pathology; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D004338:Drug Combinations; D005260:Female; D006190:Haemophilus / Q000302:isolation & purification; D006801:Humans; D008297:Male; D008875:Middle Aged; D009343:Neisseria / Q000302:isolation & purification; D013183:Sputum / Q000166:cytology / Q000382:microbiology; D013210:Staphylococcus / Q000302:isolation & purification; D013296:Streptococcus pneumoniae / Q000302:isolation & purification; D013420:Sulfamethoxazole / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D014295:Trimethoprim / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use
D004338:Drug Combinations; D000667:Ampicillin; D014295:Trimethoprim; D013420:Sulfamethoxazole